Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

BACKGROUND: The relationship between vedolizumab trough levels and combined endoscopic and clinical remission is unknown. OBJECTIVE: To compare vedolizumab trough levels in patients with and without combined remission within the first year of treatment. METHODS: We prospectively collected vedolizuma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:United European Gastroenterol J
Prif Awduron: Hanžel, Jurij, Sever, Nejc, Ferkolj, Ivan, Štabuc, Borut, Smrekar, Nataša, Kurent, Tina, Koželj, Matic, Novak, Gregor, Compernolle, Griet, Tops, Sophie, Gils, Ann, Drobne, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620872/
https://ncbi.nlm.nih.gov/pubmed/31316778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619840211
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg